Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
GLP-1 Receptor Agonist Market Report 2026 Global Outlook By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs), By Route Of Administration (Parenteral, Oral), By End Users (Hospitals, Surgical Clinics, Other Users) Market Size, Trends, Strategies, and Forecast to 2035 GLP-1 Receptor Agonist Market Overview GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025 Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity North America was the largest region in 2025 and Asia-Pacific is the fastest growing region
The New England Journal of Medicine, 375 (4), 311322
R2GConnect hosts more than 500 digital obesity and weight loss solutions
GLP-1 peptide molecules are too large to pass through the skin and enter the bloodstream
Where should I park?+ Parking is free in the spa parking lot at New Braunfels Marketplace
US$ 28.59
US$ 21.66
US$ 21.51
US$ 26.29
US$ 26.99
US$ 22.57
